Ebos Group Ltd
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligenc… Read more
Ebos Group Ltd (EBO) - Net Assets
Latest net assets as of June 2025: AU$2.93 Billion AUD
Based on the latest financial reports, Ebos Group Ltd (EBO) has net assets worth AU$2.93 Billion AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$7.84 Billion) and total liabilities (AU$4.90 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$2.93 Billion |
| % of Total Assets | 37.42% |
| Annual Growth Rate | 23.19% |
| 5-Year Change | 94.19% |
| 10-Year Change | 169.75% |
| Growth Volatility | 53.81 |
Ebos Group Ltd - Net Assets Trend (1995–2025)
This chart illustrates how Ebos Group Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ebos Group Ltd (1995–2025)
The table below shows the annual net assets of Ebos Group Ltd from 1995 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$2.93 Billion | +10.99% |
| 2024-06-30 | AU$2.64 Billion | +5.42% |
| 2023-06-30 | AU$2.51 Billion | +5.07% |
| 2022-06-30 | AU$2.39 Billion | +57.95% |
| 2021-06-30 | AU$1.51 Billion | +7.65% |
| 2020-06-30 | AU$1.40 Billion | +8.21% |
| 2019-06-30 | AU$1.30 Billion | +6.61% |
| 2018-06-30 | AU$1.22 Billion | +5.54% |
| 2017-06-30 | AU$1.15 Billion | +5.99% |
| 2016-06-30 | AU$1.09 Billion | +3.45% |
| 2015-06-30 | AU$1.05 Billion | +7.35% |
| 2014-06-30 | AU$979.04 Million | +221.13% |
| 2013-06-30 | AU$304.88 Million | +46.15% |
| 2012-06-30 | AU$208.60 Million | +4.93% |
| 2011-06-30 | AU$198.80 Million | +8.76% |
| 2010-06-30 | AU$182.79 Million | +12.81% |
| 2009-06-30 | AU$162.04 Million | +10.00% |
| 2008-06-30 | AU$147.30 Million | +56.46% |
| 2007-06-30 | AU$94.15 Million | +68.84% |
| 2006-06-30 | AU$55.76 Million | +2.45% |
| 2005-06-30 | AU$54.43 Million | +12.61% |
| 2004-06-30 | AU$48.34 Million | +8.47% |
| 2003-06-30 | AU$44.56 Million | -3.10% |
| 2002-06-30 | AU$45.99 Million | +18.33% |
| 2001-06-30 | AU$38.86 Million | +213.29% |
| 1999-06-30 | AU$12.40 Million | +17.02% |
| 1998-06-30 | AU$10.60 Million | +12.05% |
| 1997-06-30 | AU$9.46 Million | +23.31% |
| 1996-06-30 | AU$7.67 Million | +36.47% |
| 1995-06-30 | AU$5.62 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ebos Group Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 16084.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | AU$540.60 Million | 18.33% |
| Common Stock | AU$2.43 Billion | 82.48% |
| Other Comprehensive Income | AU$-23.77 Million | -0.81% |
| Total Equity | AU$2.95 Billion | 100.00% |
Ebos Group Ltd Competitors by Market Cap
The table below lists competitors of Ebos Group Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Chongqing Zhifei Bio Products
SHE:300122
|
$2.17 Billion |
|
CSI Solar Co. Ltd. A
SHG:688472
|
$2.17 Billion |
|
Retail Opportunity Investments
NASDAQ:ROIC
|
$2.18 Billion |
|
Beijing GeoEnviron Engineering
SHG:603588
|
$2.18 Billion |
|
Sh Belling
SHG:600171
|
$2.17 Billion |
|
Shanghai Jin Jiang International Hotels Development Co Ltd A
SHG:600754
|
$2.17 Billion |
|
Par Pacific Holdings Inc
NYSE:PARR
|
$2.17 Billion |
|
Jiangsu Aucksun Co Ltd
SHE:002245
|
$2.17 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ebos Group Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,683,815,618 to 2,949,891,245, a change of 266,075,627 (9.9%).
- Net income of 231,655,000 contributed positively to equity growth.
- Dividend payments of 147,564,337 reduced retained earnings.
- New share issuances of 268,955,529 increased equity.
- Other comprehensive income decreased equity by 11,016,544.
- Other factors decreased equity by 75,954,021.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$231.66 Million | +7.85% |
| Dividends Paid | AU$147.56 Million | -5.0% |
| Share Issuances | AU$268.96 Million | +9.12% |
| Other Comprehensive Income | AU$-11.02 Million | -0.37% |
| Other Changes | AU$-75.95 Million | -2.57% |
| Total Change | AU$- | 9.91% |
Book Value vs Market Value Analysis
This analysis compares Ebos Group Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.23x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 27.76x to 1.23x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-06-30 | AU$0.66 | AU$18.36 | x |
| 1996-06-30 | AU$0.90 | AU$18.36 | x |
| 1997-06-30 | AU$1.06 | AU$18.36 | x |
| 1998-06-30 | AU$1.19 | AU$18.36 | x |
| 1999-06-30 | AU$0.70 | AU$18.36 | x |
| 2000-06-30 | AU$1.45 | AU$18.36 | x |
| 2001-06-30 | AU$1.26 | AU$18.36 | x |
| 2002-06-30 | AU$1.47 | AU$18.36 | x |
| 2003-06-30 | AU$1.42 | AU$18.36 | x |
| 2004-06-30 | AU$1.52 | AU$18.36 | x |
| 2005-06-30 | AU$1.59 | AU$18.36 | x |
| 2006-06-30 | AU$1.76 | AU$18.36 | x |
| 2007-06-30 | AU$2.52 | AU$18.36 | x |
| 2008-06-30 | AU$2.89 | AU$18.36 | x |
| 2009-06-30 | AU$2.94 | AU$18.36 | x |
| 2010-06-30 | AU$3.19 | AU$18.36 | x |
| 2011-06-30 | AU$3.35 | AU$18.36 | x |
| 2012-06-30 | AU$3.48 | AU$18.36 | x |
| 2013-06-30 | AU$5.71 | AU$18.36 | x |
| 2014-06-30 | AU$6.67 | AU$18.36 | x |
| 2015-06-30 | AU$7.02 | AU$18.36 | x |
| 2016-06-30 | AU$7.19 | AU$18.36 | x |
| 2017-06-30 | AU$7.46 | AU$18.36 | x |
| 2018-06-30 | AU$7.85 | AU$18.36 | x |
| 2019-06-30 | AU$8.48 | AU$18.36 | x |
| 2020-06-30 | AU$8.71 | AU$18.36 | x |
| 2021-06-30 | AU$9.26 | AU$18.36 | x |
| 2022-06-30 | AU$14.19 | AU$18.36 | x |
| 2023-06-30 | AU$13.90 | AU$18.36 | x |
| 2024-06-30 | AU$13.97 | AU$18.36 | x |
| 2025-06-30 | AU$14.95 | AU$18.36 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ebos Group Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.85%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.75%
- • Asset Turnover: 1.69x
- • Equity Multiplier: 2.66x
- Recent ROE (7.85%) is below the historical average (14.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 39.72% | 7.98% | 2.22x | 2.24x | AU$1.67 Million |
| 1996 | 45.37% | 0.00% | 0.00x | 1.81x | AU$2.71 Million |
| 1997 | 31.52% | 5.22% | 2.19x | 2.75x | AU$2.04 Million |
| 1998 | 26.08% | 0.00% | 0.00x | 2.78x | AU$1.70 Million |
| 1999 | 34.27% | 0.00% | 0.00x | 2.84x | AU$3.01 Million |
| 2000 | 0.53% | 0.00% | 0.00x | 0.00x | AU$-3.36 Million |
| 2001 | 13.34% | 4.90% | 1.75x | 1.55x | AU$1.30 Million |
| 2002 | -0.82% | -0.18% | 2.28x | 1.97x | AU$-4.98 Million |
| 2003 | -0.25% | -0.05% | 2.42x | 2.08x | AU$-4.57 Million |
| 2004 | 17.44% | 3.69% | 2.46x | 1.92x | AU$3.59 Million |
| 2005 | 17.88% | 3.22% | 2.35x | 2.36x | AU$3.97 Million |
| 2006 | 20.71% | 3.85% | 2.23x | 2.42x | AU$5.97 Million |
| 2007 | 10.96% | 3.36% | 2.24x | 1.46x | AU$904.00K |
| 2008 | 11.31% | 1.53% | 2.24x | 3.30x | AU$1.93 Million |
| 2009 | 12.17% | 1.47% | 2.68x | 3.08x | AU$3.52 Million |
| 2010 | 12.82% | 1.71% | 2.64x | 2.84x | AU$5.16 Million |
| 2011 | 15.89% | 2.35% | 2.49x | 2.71x | AU$11.70 Million |
| 2012 | 13.40% | 1.96% | 2.17x | 3.15x | AU$7.09 Million |
| 2013 | 9.25% | 1.83% | 0.61x | 8.30x | AU$-2.28 Million |
| 2014 | 9.40% | 1.60% | 2.49x | 2.36x | AU$-5.83 Million |
| 2015 | 10.08% | 1.75% | 2.38x | 2.43x | AU$838.20K |
| 2016 | 11.68% | 1.79% | 2.22x | 2.94x | AU$18.27 Million |
| 2017 | 11.73% | 1.74% | 2.38x | 2.83x | AU$19.64 Million |
| 2018 | 12.54% | 1.97% | 2.33x | 2.74x | AU$30.27 Million |
| 2019 | 11.08% | 1.99% | 2.16x | 2.58x | AU$14.09 Million |
| 2020 | 12.36% | 1.85% | 2.34x | 2.85x | AU$33.20 Million |
| 2021 | 13.13% | 2.01% | 2.33x | 2.80x | AU$47.49 Million |
| 2022 | 8.95% | 1.89% | 1.71x | 2.77x | AU$-26.47 Million |
| 2023 | 10.41% | 2.07% | 1.90x | 2.64x | AU$10.81 Million |
| 2024 | 11.06% | 2.06% | 1.96x | 2.75x | AU$28.33 Million |
| 2025 | 7.85% | 1.75% | 1.69x | 2.66x | AU$-63.33 Million |
Industry Comparison
This section compares Ebos Group Ltd's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $17,249,392
- Average return on equity (ROE) among peers: -8.84%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ebos Group Ltd (EBO) | AU$2.93 Billion | 39.72% | 1.67x | $2.17 Billion |
| Cyclopharm Ltd (CYC) | $17.25 Million | -8.84% | 0.36x | $24.34 Million |